Engineering embryonic stem cells with recombinase systems

Methods Enzymol. 2006:420:100-36. doi: 10.1016/S0076-6879(06)20007-7.

Abstract

The combined use of site-specific recombination and gene targeting or trapping in embryonic stem cells (ESCs) has resulted in the emergence of technologies that enable the induction of mouse mutations in a prespecified temporal and spatially restricted manner. Their large-scale implementation by several international mouse mutagenesis programs will lead to the assembly of a library of ES cell lines harboring conditional mutations in every single gene of the mouse genome. In anticipation of this unprecedented resource, this chapter will focus on site-specific recombination strategies and issues pertinent to ESCs and mice. The upcoming ESC resource and the increasing sophistication of site-specific recombination technologies will greatly assist the functional annotation of the human genome and the animal modeling of human disease.

MeSH terms

  • Animals
  • DNA Nucleotidyltransferases / genetics
  • DNA Nucleotidyltransferases / physiology*
  • Embryonic Stem Cells / cytology*
  • Gene Library
  • Genetic Engineering / methods*
  • Integrases / genetics
  • Integrases / physiology*
  • Mice
  • Mutagenesis, Site-Directed / methods
  • Recombination, Genetic

Substances

  • Cre recombinase
  • DNA Nucleotidyltransferases
  • FLP recombinase
  • Integrases